» Articles » PMID: 25416366

The Use of Mitochondria-targeted Endonucleases to Manipulate MtDNA

Overview
Journal Methods Enzymol
Specialty Biochemistry
Date 2014 Nov 23
PMID 25416366
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

For more than a decade, mitochondria-targeted nucleases have been used to promote double-strand breaks in the mitochondrial genome. This was done in mitochondrial DNA (mtDNA) homoplasmic systems, where all mtDNA molecules can be affected, to create models of mitochondrial deficiencies. Alternatively, they were also used in a heteroplasmic model, where only a subset of the mtDNA molecules were substrates for cleavage. The latter approach showed that mitochondrial-targeted nucleases can reduce mtDNA haplotype loads in affected tissues, with clear implications for the treatment of patients with mitochondrial diseases. In the last few years, designer nucleases, such as ZFN and TALEN, have been adapted to cleave mtDNA, greatly expanding the potential therapeutic use. This chapter describes the techniques and approaches used to test these designer enzymes.

Citing Articles

Heterogeneous brain region-specific responses to astrocytic mitochondrial DNA damage in mice.

Ayala D, Matarazzo A, Seaberg B, Patel M, Tijerina E, Matthews C Sci Rep. 2024; 14(1):18586.

PMID: 39127716 PMC: 11316820. DOI: 10.1038/s41598-024-69499-w.


Induce male sterility by CRISPR/Cas9-mediated mitochondrial genome editing in tobacco.

Chang Y, Liu B, Jiang Y, Cao D, Liu Y, Li Y Funct Integr Genomics. 2023; 23(3):205.

PMID: 37335501 DOI: 10.1007/s10142-023-01136-7.


Gene therapy for primary mitochondrial diseases: experimental advances and clinical challenges.

Falabella M, Minczuk M, Hanna M, Viscomi C, Pitceathly R Nat Rev Neurol. 2022; 18(11):689-698.

PMID: 36257993 DOI: 10.1038/s41582-022-00715-9.


Potential of Mitochondrial Genome Editing for Human Fertility Health.

Fu L, Luo Y, Liu Y, Liu H, Li H, Yu Y Front Genet. 2021; 12:673951.

PMID: 34354734 PMC: 8329452. DOI: 10.3389/fgene.2021.673951.


Modelling Mitochondrial Disease in Human Pluripotent Stem Cells: What Have We Learned?.

McKnight C, Low Y, Elliott D, Thorburn D, Frazier A Int J Mol Sci. 2021; 22(14).

PMID: 34299348 PMC: 8306397. DOI: 10.3390/ijms22147730.


References
1.
Pinto M, Moraes C . Mitochondrial genome changes and neurodegenerative diseases. Biochim Biophys Acta. 2013; 1842(8):1198-207. PMC: 4283582. DOI: 10.1016/j.bbadis.2013.11.012. View

2.
Toompuu M, Tiranti V, Zeviani M, Jacobs H . Molecular phenotype of the np 7472 deafness-associated mitochondrial mutation in osteosarcoma cell cybrids. Hum Mol Genet. 1999; 8(12):2275-83. DOI: 10.1093/hmg/8.12.2275. View

3.
Moraes C . What regulates mitochondrial DNA copy number in animal cells?. Trends Genet. 2001; 17(4):199-205. DOI: 10.1016/s0168-9525(01)02238-7. View

4.
Battersby B, Shoubridge E . Selection of a mtDNA sequence variant in hepatocytes of heteroplasmic mice is not due to differences in respiratory chain function or efficiency of replication. Hum Mol Genet. 2001; 10(22):2469-79. DOI: 10.1093/hmg/10.22.2469. View

5.
Srivastava S, Moraes C . Manipulating mitochondrial DNA heteroplasmy by a mitochondrially targeted restriction endonuclease. Hum Mol Genet. 2001; 10(26):3093-9. DOI: 10.1093/hmg/10.26.3093. View